Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:LCI

Lannett (LCI) Stock Price, News & Analysis

Lannett logo

About Lannett Stock (NYSE:LCI)

Key Stats

Today's Range
N/A
50-Day Range
$0.65
$2.51
52-Week Range
N/A
Volume
280,600 shs
Average Volume
92,067 shs
Market Capitalization
$7.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.

Receive LCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lannett and its competitors with MarketBeat's FREE daily newsletter.

LCI Stock News Headlines

Lucky Core Industries Ltd.
We recommended Nvidia in 2016, now we’re recommending this…
The AI boom is just getting started. And the real wealth has still to be made…
LANNETT SHARES UPDATE
Why Lannett (LCI) Stock Is Down Today
See More Headlines

LCI Stock Analysis - Frequently Asked Questions

Lannett Company, Inc. (NYSE:LCI) announced its quarterly earnings data on Wednesday, November, 3rd. The company reported ($1.08) EPS for the quarter, missing analysts' consensus estimates of ($1.00) by $0.08. The business had revenue of $101.53 million for the quarter, compared to the consensus estimate of $98.62 million.

Lannett shares reverse split before market open on Tuesday, February 7th 2023. The 1-4 reverse split was announced on Tuesday, February 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lannett investors own include Bristol-Myers Squibb (BMY), Akorn (AKRX), Micron Technology (MU), Skechers U.S.A. (SKX), Integrated Device Technology (IDTI), AT&T (T) and Bank of America (BAC).

Company Calendar

Last Earnings
11/03/2021
Today
11/02/2024
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
CUSIP
51601210
Employees
810
Year Founded
N/A

Profitability

Net Income
$-231,620,000.00
Pretax Margin
-62.67%

Debt

Sales & Book Value

Annual Sales
$340.58 million
Book Value
($23.34) per share

Miscellaneous

Free Float
9,354,000
Market Cap
$7.38 million
Optionable
Optionable
Beta
0.95

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (NYSE:LCI) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners